Influenza Diagnostics Market Unlock the Future: 2030 Market Report and Forecast
Global Influenza Diagnostics Market Size Was Valued at USD 1.11 Billion in 2022, and is Projected to Reach USD 1.47 Billion by 2030, Growing at a CAGR of 3.6% From 2023-2030.
The manufacture, marketing, and application of diagnostic instruments and assays intended to find and identify influenza viruses in clinical specimens are all included in the influenza diagnostics market. Healthcare providers can start the proper treatment and infection control measures when these diagnostics help identify influenza illnesses quickly and accurately. Serological assays, viral culture methods, nucleic acid amplification tests (NAATs), and fast antigen tests are important market players. Seasonal influenza outbreaks, the advent of novel influenza strains, the need of early diagnosis for efficient patient management, and public health surveillance initiatives are some of the factors propelling the market's expansion. Hospitals, clinics, and laboratories are among the healthcare facilities that are served by the influenza diagnostics market.
Global Influenza Diagnostics Market Top Key Players:
Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-LA Roche AG (Switzerland), Abbott Laboratories Inc. (Us), Hologic Inc. (US), SEKISUI Diagnostics (US), Quidel Corporation (US), Germaine Laboratories Inc. (US), Dickinson and Company (US), Meridian Bioscience (US), GenMark Diagnostics Inc. (US), Luminex Corporation (US), SA Scientific Ltd. (US), bioMérieux SA (France), Tecan Trading AG (Switzerland), DiaSorin SA (Italy), altona Diagnostics GmbH (Germany), Coris BioConcept SPRL (Belgium), ELITech Group (France), Mast Group Ltd. (UK), Genome Diagnostics Pvt. Ltd. (India), Response Biomedical Corp. (Canada), Tauns LaboratoriesInc. (Japan), 3B BlackBio Biotech India Ltd. (India)
Start with a Free Sample Report Today!
Introspective Market Research provide comprehensive market research studies, delivering valuable insights and strategic guidance to businesses worldwide. Our operations are driven by accurate analysis and extensive coverage of all the areas to offer reliable reports.
Our study encompasses major growth determinants and drivers, along with extensive segmentation areas. Through in-depth analysis of supply and sales channels, including upstream and downstream fundamentals, we present a complete market ecosystem.
To ensure accuracy and reliability, our research leverages numerous primary and secondary sources. We employ industry-standard tools such as Porter's Five Forces Analysis, Swot Analysis, And Price Trend Analysis. Our extensive geographical coverage allows for a comprehensive understanding of regional trends and externally affecting factors.
Discount on the Research Report@
Segmentation Analysis of The Influenza Diagnostics Market
Global Influenza Diagnostics Market Segmented on the basis of type, application, and end-users.
By Type
Traditional
Rapid Influenza Detection Tests
Viral Culture
Immunoassay Kits
Molecular
Rapid Molecular Assays
Reverse Transcription-Polymerase Chain Reaction {Rt-Pcr}
Nucleic Acid Amplification
By End Users
Clinical Laboratories
Hospitals
Research & Academic Institutes
Diagnostic Laboratories
Your Vision, Your Report - We'll Make It Happen!
Global Influenza Diagnostics Market Trend Analysis
Growth in influenza research for diagnostic technologies
The influenza diagnostics market has grown significantly as a result of the quick developments in diagnostic technology. The urgent need for precise, timely, and effective detection techniques has led to a rush in research in influenza diagnostics. The advancement of technology has facilitated the creation of innovative diagnostic instruments, such as molecular assays, point-of-care examinations, and sophisticated imaging methods, augmenting the accuracy and velocity of influenza identification. These cutting-edge technologies support efficient disease management and surveillance, which are essential for stopping outbreaks and limiting the transmission of influenza viruses. They also make early and accurate diagnosis easier.
Advancements In Genomic And Proteomic Technologies
The influenza diagnostics market offers a wide range of prospects due to the development of proteomic and genomic technologies. The genomes of influenza viruses are now well understood thanks to genomic methods like polymerase chain reaction (PCR) and next-generation sequencing (NGS). These developments have made it easier to identify different influenza strains—including new and emerging ones—quickly and accurately. Diagnostic methods can be made more sensitive and specific in identifying influenza strains by detecting particular viral mutations or genetic markers by understanding the genetic information of viruses.
By Region
North America (US, Canada, Mexico)
Eastern Europe (Bulgaria, The Cz
Global Influenza Diagnostics Market Size Was Valued at USD 1.11 Billion in 2022, and is Projected to Reach USD 1.47 Billion by 2030, Growing at a CAGR of 3.6% From 2023-2030.
The manufacture, marketing, and application of diagnostic instruments and assays intended to find and identify influenza viruses in clinical specimens are all included in the influenza diagnostics market. Healthcare providers can start the proper treatment and infection control measures when these diagnostics help identify influenza illnesses quickly and accurately. Serological assays, viral culture methods, nucleic acid amplification tests (NAATs), and fast antigen tests are important market players. Seasonal influenza outbreaks, the advent of novel influenza strains, the need of early diagnosis for efficient patient management, and public health surveillance initiatives are some of the factors propelling the market's expansion. Hospitals, clinics, and laboratories are among the healthcare facilities that are served by the influenza diagnostics market.
Global Influenza Diagnostics Market Top Key Players:
Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-LA Roche AG (Switzerland), Abbott Laboratories Inc. (Us), Hologic Inc. (US), SEKISUI Diagnostics (US), Quidel Corporation (US), Germaine Laboratories Inc. (US), Dickinson and Company (US), Meridian Bioscience (US), GenMark Diagnostics Inc. (US), Luminex Corporation (US), SA Scientific Ltd. (US), bioMérieux SA (France), Tecan Trading AG (Switzerland), DiaSorin SA (Italy), altona Diagnostics GmbH (Germany), Coris BioConcept SPRL (Belgium), ELITech Group (France), Mast Group Ltd. (UK), Genome Diagnostics Pvt. Ltd. (India), Response Biomedical Corp. (Canada), Tauns LaboratoriesInc. (Japan), 3B BlackBio Biotech India Ltd. (India)
Start with a Free Sample Report Today!
Introspective Market Research provide comprehensive market research studies, delivering valuable insights and strategic guidance to businesses worldwide. Our operations are driven by accurate analysis and extensive coverage of all the areas to offer reliable reports.
Our study encompasses major growth determinants and drivers, along with extensive segmentation areas. Through in-depth analysis of supply and sales channels, including upstream and downstream fundamentals, we present a complete market ecosystem.
To ensure accuracy and reliability, our research leverages numerous primary and secondary sources. We employ industry-standard tools such as Porter's Five Forces Analysis, Swot Analysis, And Price Trend Analysis. Our extensive geographical coverage allows for a comprehensive understanding of regional trends and externally affecting factors.
Discount on the Research Report@
Segmentation Analysis of The Influenza Diagnostics Market
Global Influenza Diagnostics Market Segmented on the basis of type, application, and end-users.
By Type
Traditional
Rapid Influenza Detection Tests
Viral Culture
Immunoassay Kits
Molecular
Rapid Molecular Assays
Reverse Transcription-Polymerase Chain Reaction {Rt-Pcr}
Nucleic Acid Amplification
By End Users
Clinical Laboratories
Hospitals
Research & Academic Institutes
Diagnostic Laboratories
Your Vision, Your Report - We'll Make It Happen!
Global Influenza Diagnostics Market Trend Analysis
Growth in influenza research for diagnostic technologies
The influenza diagnostics market has grown significantly as a result of the quick developments in diagnostic technology. The urgent need for precise, timely, and effective detection techniques has led to a rush in research in influenza diagnostics. The advancement of technology has facilitated the creation of innovative diagnostic instruments, such as molecular assays, point-of-care examinations, and sophisticated imaging methods, augmenting the accuracy and velocity of influenza identification. These cutting-edge technologies support efficient disease management and surveillance, which are essential for stopping outbreaks and limiting the transmission of influenza viruses. They also make early and accurate diagnosis easier.
Advancements In Genomic And Proteomic Technologies
The influenza diagnostics market offers a wide range of prospects due to the development of proteomic and genomic technologies. The genomes of influenza viruses are now well understood thanks to genomic methods like polymerase chain reaction (PCR) and next-generation sequencing (NGS). These developments have made it easier to identify different influenza strains—including new and emerging ones—quickly and accurately. Diagnostic methods can be made more sensitive and specific in identifying influenza strains by detecting particular viral mutations or genetic markers by understanding the genetic information of viruses.
By Region
North America (US, Canada, Mexico)
Eastern Europe (Bulgaria, The Cz
8 months ago
